Patent · US Expired

&agr;-hydroxyarylbutanamine inhibitors of aspartyl protease

US6696494B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignee

Enanta Pharmaceuticals, Inc. · US

Inventors

Yat Sun Or · Watertown, US
Guoqiang Wang · Shandong, CN
John Rougas · Irwin, US
Jude Mathews · Waltham, US
Kate Ryan Muldoon · Watertown, US
Vincent A. Boyd · Tyler, US
Jens Eckstein · Dachau, DE
Steven Wayne Riesinger · Stoneham, US

Key dates

Filing date	Oct 22, 2001
Grant date	Feb 24, 2004
Priority date	—
Expiry date	Oct 22, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Acylated &agr;-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these compounds. The compounds have the formula: A representative example is:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.